Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conor Barry

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cellular Oncology (Dordrecht, Netherlands)|January 1, 2017
ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short reportLorenz Kadletz, Gregor Heiduschka, Robert Wiebringhaus, et al.
American Journal of Respiratory and Critical Care Medicine|January 4, 2022
Rapid-Onset Cystic Bronchiectasis in a Mechanically Ventilated Patient with COVID-19Michael Gilmartin, Ahmad Basirat, Conor Barry, et al.
Bioconjugate Chemistry|December 4, 2019
Improved Physical Stability of an Antibody-Drug Conjugate Using Host-Guest ChemistrySilvia Sonzini, Maria Laura Greco, Thais Cailleau, et al.
Laryngoscope Investigative Otolaryngology|August 17, 2021
Pre-operative testing for SARS-CoV-2 and outcomes in otolaryngology surgery during the pandemic: A multi-center experienceFergal G Kavanagh, Deirdre Callanan, Carmel Connolly, et al.
Molecular Oncology|November 19, 2019
TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumorsMarco Gymnopoulos, Oscar Betancourt, Vincent Blot, et al.
Molecular Cancer Therapeutics|August 19, 2016
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological MalignanciesMichael J Flynn, Francesca Zammarchi, Peter C Tyrer, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cellular Oncology (Dordrecht, Netherlands)|January 1, 2017
ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short reportLorenz Kadletz, Gregor Heiduschka, Robert Wiebringhaus, et al.
American Journal of Respiratory and Critical Care Medicine|January 4, 2022
Rapid-Onset Cystic Bronchiectasis in a Mechanically Ventilated Patient with COVID-19Michael Gilmartin, Ahmad Basirat, Conor Barry, et al.
Bioconjugate Chemistry|December 4, 2019
Improved Physical Stability of an Antibody-Drug Conjugate Using Host-Guest ChemistrySilvia Sonzini, Maria Laura Greco, Thais Cailleau, et al.
Laryngoscope Investigative Otolaryngology|August 17, 2021
Pre-operative testing for SARS-CoV-2 and outcomes in otolaryngology surgery during the pandemic: A multi-center experienceFergal G Kavanagh, Deirdre Callanan, Carmel Connolly, et al.
Molecular Oncology|November 19, 2019
TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumorsMarco Gymnopoulos, Oscar Betancourt, Vincent Blot, et al.
Molecular Cancer Therapeutics|August 19, 2016
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological MalignanciesMichael J Flynn, Francesca Zammarchi, Peter C Tyrer, et al.
Pageof 2